Successful treatment of neuroleptic malignant syndrome with sodium nitroprusside.
D003131:Combined Modality Therapy; D005260:Female; D005292:Ferricyanides / Q000627:therapeutic use*; D005476:Fluphenazine / Q000009:adverse effects / Q000031:analogs & derivatives; D006801:Humans; D008152:Loxapine / Q000009:adverse effects; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy*; D009599:Nitroprusside / Q000627:therapeutic use*; D014661:Vasoconstriction / Q000187:drug effects
D005292:Ferricyanides; D009599:Nitroprusside; C011825:fluphenazine depot; D008152:Loxapine; D005476:Fluphenazine